{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:23Z","timestamp":1792790483154,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Acute Myeloid Leukemia (AML) is a highly heterogeneous hematologic malignancy influenced by various factors affecting prognosis. Recently, the role of coagulation-related genes in tumor biology has garnered increasing attention. This study aims to investigate the expression patterns of coagulation-related genes in AML and their clinical relevance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We obtained RNA-seq data and clinical information for AML patients from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO), followed by data cleaning and normalization. Unsupervised consensus clustering was performed to identify molecular subtypes, and Kaplan\u2013Meier survival analysis was utilized to assess survival differences. We further identified differentially expressed genes (DEGs) between groups and conducted functional enrichment analyses. Additionally, a prognostic model was constructed using machine learning techniques, and its prognostic ability was validated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Clustering analysis categorized 151 tumor samples into the high coagulation-related gene expression group (C1, high-expression) and the low coagulation-related gene expression group (C2, low-expression), revealing 1,747 DEGs. Functional enrichment analysis indicated that DEGs were mainly associated with leukocyte migration and cytokine signaling pathways. Immune landscape analysis showed that the high expression group had elevated immune and stromal scores, distinct immune cell infiltration patterns, and a higher ESTIMATE score. The constructed coagulation score risk model indicated that age, cytogenetics, and risk scores were significantly associated with AML prognosis. Furthermore, intersection analysis using three machine learning methods identified MMP7 and F12 as key biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study demonstrates that coagulation-related genes play a crucial role in the molecular characteristics, prognostic assessment, and immune modulation in AML. MMP7 and F12 are highlighted as potential biomarkers that could aid in optimizing the diagnosis and treatment strategies for AML. These findings offer new insights into personalized therapies for AML.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-02975-9","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T07:35:22Z","timestamp":1754897722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the role of coagulation-related genes in acute myeloid leukemia prognosis and immune microenvironment through machine learning"],"prefix":"10.1186","volume":"30","author":[{"given":"Liyun","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"2975_CR1","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2975_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2975_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1089\/dna.2020.5667","volume":"39","author":"X-X Chen","year":"2020","unstructured":"Chen X-X, Li Z-P, Zhu J-H, Xia H-T, Zhou H. Systematic analysis of autophagy-related signature uncovers prognostic predictor for acute myeloid leukemia. DNA Cell Biol. 2020;39(9):1595\u2013605.","journal-title":"DNA Cell Biol"},{"issue":"3","key":"2975_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/ph15030320","volume":"15","author":"S-Y Han","year":"2022","unstructured":"Han S-Y. Small molecule induced FLT3 degradation. Pharmaceuticals. 2022;15(3):320.","journal-title":"Pharmaceuticals"},{"issue":"22","key":"2975_CR5","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1002\/cam4.4764","volume":"11","author":"S Chen","year":"2022","unstructured":"Chen S, Zhu H, Jin M, Yuan H, Liu Z, Li J, et al. Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies. Cancer Med. 2022;11(22):4122\u201333.","journal-title":"Cancer Med"},{"issue":"4","key":"2975_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347.","journal-title":"Blood"},{"issue":"6","key":"2975_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715\u201322.","journal-title":"JAMA"},{"issue":"10","key":"2975_CR8","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712\u201323.","journal-title":"Blood"},{"issue":"14","key":"2975_CR9","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959\u201369.","journal-title":"Blood"},{"issue":"8","key":"2975_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/jth.14475","volume":"17","author":"K Adelborg","year":"2019","unstructured":"Adelborg K, Corraini P, Darvalics B, Frederiksen H, Ording A, Horv\u00e1th-Puh\u00f3 E, et al. Risk of thromboembolic and bleeding outcomes following hematological cancers: a Danish population-based cohort study. J Thromb Haemost. 2019;17(8):1305\u201318.","journal-title":"J Thromb Haemost"},{"key":"2975_CR11","doi-asserted-by":"publisher","first-page":"1394585","DOI":"10.3389\/fmolb.2024.1394585","volume":"11","author":"C Lei","year":"2024","unstructured":"Lei C, Li Y, Yang H, Zhang K, Lu W, Wang N, et al. Unraveling breast cancer prognosis: a novel model based on coagulation-related genes. Front Mol Biosci. 2024;11:1394585.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"2975_CR12","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.4103\/1673-5374.262568","volume":"14","author":"SG Gofrit","year":"2019","unstructured":"Gofrit SG, Shavit-Stein E. The neuro-glial coagulonome: the thrombin receptor and coagulation pathways as major players in neurological diseases. Neural Regen Res. 2019;14(12):2043\u201353.","journal-title":"Neural Regen Res"},{"issue":"9","key":"2975_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1182\/blood.2020005710","volume":"137","author":"MJ Feinauer","year":"2021","unstructured":"Feinauer MJ, Schneider SW, Berghoff AS, Robador JR, Tehranian C, Karreman MA, et al. Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model. Blood. 2021;137(9):1219\u201332.","journal-title":"Blood"},{"issue":"1","key":"2975_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jacc.2017.10.072","volume":"71","author":"R Dann","year":"2018","unstructured":"Dann R, Hadi T, Montenont E, Boytard L, Alebrahim D, Feinstein J, et al. Platelet-derived MRP-14 induces monocyte activation in patients with symptomatic peripheral artery disease. J Am Coll Cardiol. 2018;71(1):53\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"2975_CR15","doi-asserted-by":"publisher","first-page":"eaaw8405","DOI":"10.1126\/sciimmunol.aaw8405","volume":"4","author":"C Graf","year":"2019","unstructured":"Graf C, Wilgenbus P, Pagel S, Pott J, Marini F, Reyda S, et al. Myeloid cell-synthesized coagulation factor X dampens antitumor immunity. Sci Immunol. 2019;4(39):eaaw8405.","journal-title":"Sci Immunol"},{"key":"2975_CR16","doi-asserted-by":"publisher","first-page":"1268090","DOI":"10.3389\/fimmu.2023.1268090","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bin T, Tang J, Xu X-J, Lin C, Lu B, et al. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes. Front Immunol. 2023;14:1268090.","journal-title":"Front Immunol"},{"key":"2975_CR17","doi-asserted-by":"publisher","first-page":"1301236","DOI":"10.3389\/fonc.2023.1301236","volume":"13","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wen R, Wu G, Li G, Wu X, Guo Y, et al. Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering. Front Oncol. 2023;13:1301236.","journal-title":"Front Oncol"},{"key":"2975_CR18","doi-asserted-by":"publisher","first-page":"1149513","DOI":"10.3389\/fimmu.2023.1149513","volume":"14","author":"G Jiang","year":"2023","unstructured":"Jiang G, Jin P, Xiao X, Shen J, Li R, Zhang Y, et al. Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia. Front Immunol. 2023;14:1149513.","journal-title":"Front Immunol"},{"issue":"1","key":"2975_CR19","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1038\/s41598-024-53306-7","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, Sun H, Dong Y, Huang J, Bai L, Tang Z, et al. Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking. Sci Rep. 2024;14(1):2802.","journal-title":"Sci Rep"},{"issue":"4","key":"2975_CR20","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/tox.24073","volume":"39","author":"H-M Hu","year":"2024","unstructured":"Hu H-M, Lee H-L, Liu C-J, Hsieh Y-H, Chen Y-S, Hsueh K-C. Loss of MTA2-mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK-MMP7 axis. Environ Toxicol. 2024;39(4):1897\u2013908.","journal-title":"Environ Toxicol"},{"issue":"3","key":"2975_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jhep.2023.11.022","volume":"80","author":"W Fan","year":"2024","unstructured":"Fan W, Cao D, Yang B, Wang J, Li X, Kitka D, et al. Hepatic prohibitin 1 and methionine adenosyltransferase \u03b11 defend against primary and secondary liver cancer metastasis. J Hepatol. 2024;80(3):443\u201353.","journal-title":"J Hepatol"},{"issue":"1","key":"2975_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12967-023-04527-3","volume":"21","author":"S Ou","year":"2023","unstructured":"Ou S, Chen H, Wang H, Ye J, Liu H, Tao Y, et al. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis. J Transl Med. 2023;21(1):704.","journal-title":"J Transl Med"},{"key":"2975_CR23","doi-asserted-by":"publisher","first-page":"574939","DOI":"10.3389\/fonc.2020.574939","volume":"10","author":"R Zhu","year":"2020","unstructured":"Zhu R, Tao H, Lin W, Tang L, Hu Y. Identification of an immune-related gene signature based on immunogenomic landscape analysis to predict the prognosis of adult acute myeloid leukemia patients. Front Oncol. 2020;10:574939.","journal-title":"Front Oncol"},{"issue":"6","key":"2975_CR24","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1002\/jcb.28351","volume":"120","author":"Y Wu","year":"2019","unstructured":"Wu Y, Pan S, Leng J, Xie T, Jamal M, Yin Q, et al. The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia. J Cell Biochem. 2019;120(6):10613\u201324.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2975_CR25","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3892\/ol.2020.11700","volume":"20","author":"G Li","year":"2020","unstructured":"Li G, Gao Y, Li K, Lin A, Jiang Z. Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia. Oncol Lett. 2020;20(2):1824\u201334.","journal-title":"Oncol Lett"},{"issue":"3","key":"2975_CR26","first-page":"3447","volume":"15","author":"J Wu","year":"2018","unstructured":"Wu J, Song Y. Expression and clinical significance of serum MMP-7 and PTEN levels in patients with acute myeloid leukemia. Oncol Lett. 2018;15(3):3447\u201352.","journal-title":"Oncol Lett"},{"issue":"15","key":"2975_CR27","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood.2022017074","volume":"141","author":"EM Sparkenbaugh","year":"2023","unstructured":"Sparkenbaugh EM, Henderson MW, Miller-Awe M, Abrams C, Ilich A, Trebak F, et al. Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood. 2023;141(15):1871\u201383.","journal-title":"Blood"},{"issue":"1","key":"2975_CR28","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.1038\/s41467-024-51745-4","volume":"15","author":"P Xu","year":"2024","unstructured":"Xu P, Zhang Y, Guo J, Li H, Konrath S, Zhou P, et al. A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation. Nat Commun. 2024;15(1):7898.","journal-title":"Nat Commun"},{"issue":"7","key":"2975_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1055\/s-0043-1769509","volume":"50","author":"A Shamanaev","year":"2024","unstructured":"Shamanaev A, Litvak M, Ivanov I, Srivastava P, Sun M-F, Dickeson SK, et al. Factor XII structure-function relationships. Semin Thromb Hemost. 2024;50(7):937\u201352.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2975_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40164-023-00378-2","volume":"12","author":"Z-Q Chen","year":"2023","unstructured":"Chen Z-Q, Zuo X-L, Cai J, Zhang Y, Han G-Y, Zhang L, et al. Hypoxia-associated circPRDM4 promotes immune escape via HIF-1\u03b1 regulation of PD-L1 in hepatocellular carcinoma. Exp Hematol Oncol. 2023;12(1):17.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"2975_CR31","first-page":"1222","volume":"12","author":"D Yan","year":"2022","unstructured":"Yan D, Cai S, Bai L, Du Z, Li H, Sun P, et al. Integration of immune and hypoxia gene signatures improves the prediction of radiosensitivity in breast cancer. Am J Cancer Res. 2022;12(3):1222\u201340.","journal-title":"Am J Cancer Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02975-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T22:49:55Z","timestamp":1757371795000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02975-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02975-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is based on publicly available data from the TCGA database. All data are de-identified, and no additional ethical approval or informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"734"}}